Covered recipient · General Payments record
IRA A TABAS
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2019
$12,837.42
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,400.00 | 2 |
| Travel and Lodging | $2,060.72 | 3 |
| Food and Beverage | $231.44 | 3 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,649.26 | 4 |
| Amgen Inc. | $3,042.90 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $76.78 | 06/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663333298 | CMS |
| Amgen Inc. | $928.52 | 09/13/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 663333301 | CMS |
| Amgen Inc. | $37.60 | 09/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663333305 | CMS |
| Amgen Inc. | $2,000.00 | 09/20/2019 | Consulting Fee | Undisputed | 01/23/2026 | 663333309 | CMS |
| Novartis Pharmaceuticals Corporation | $445.21 | 07/15/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 660040329 | CMS |
| Novartis Pharmaceuticals Corporation | $2,400.00 | 07/15/2019 | Consulting Fee | Undisputed | 01/23/2026 | 660040331 | CMS |
| Novartis Pharmaceuticals Corporation | $117.06 | 07/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 660040333 | CMS |
| Novartis Pharmaceuticals Corporation | $686.99 | 07/15/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 660040335 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.